Published in Invert Neurosci on April 27, 2011
Spermidine promotes stress resistance in Drosophila melanogaster through autophagy-dependent and -independent pathways. Cell Death Dis (2012) 1.10
Resveratrol and calcium signaling: molecular mechanisms and clinical relevance. Molecules (2014) 0.89
A survey of the protective effects of some commercially available antioxidant supplements in genetically and chemically induced models of oxidative stress in Drosophila melanogaster. Exp Gerontol (2012) 0.76
Fumigant activity of the Psidium guajava var. pomifera (Myrtaceae) essential oil in Drosophila melanogaster by means of oxidative stress. Oxid Med Cell Longev (2014) 0.75
Phycoerythrin averts intracellular ROS generation and physiological functional decline in eukaryotes under oxidative stress. Protoplasma (2016) 0.75
Resveratrol improves health and survival of mice on a high-calorie diet. Nature (2006) 20.91
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell (2006) 19.16
Parkinson's disease: mechanisms and models. Neuron (2003) 14.84
'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature (2007) 5.03
The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain (1999) 4.25
Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development (2004) 3.03
Calcium and neurodegeneration. Aging Cell (2007) 2.90
Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mech Ageing Dev (2007) 2.75
A portrait of locomotor behaviour in Drosophila determined by a video-tracking paradigm. Behav Processes (2004) 2.61
Design and synthesis of compounds that extend yeast replicative lifespan. Aging Cell (2006) 1.93
Genome wide analysis of common and specific stress responses in adult drosophila melanogaster. BMC Genomics (2004) 1.82
Calcium, ageing, and neuronal vulnerability in Parkinson's disease. Lancet Neurol (2007) 1.71
Drosophila melanogaster neurobiology, neuropharmacology, and how the fly can inform central nervous system drug discovery. Pharmacol Ther (2006) 1.45
Risk factors for parkinson's disease: the leisure world cohort study. Neuroepidemiology (2001) 1.43
Paraquat exposure as an etiological factor of Parkinson's disease. Neurotoxicology (2006) 1.39
Calcium homeostasis, selective vulnerability and Parkinson's disease. Trends Neurosci (2009) 1.34
Interaction of genetic and environmental factors in a Drosophila parkinsonism model. J Neurosci (2007) 1.33
Neurobiology and treatment of Parkinson's disease. Trends Pharmacol Sci (2008) 1.32
L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia. J Neurochem (2009) 1.28
Calcium signaling in neurodegeneration. Mol Neurodegener (2009) 1.27
Resveratrol as a therapeutic agent for neurodegenerative diseases. Mol Neurobiol (2010) 1.23
Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models. Aging Cell (2009) 1.22
Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol. Parkinsonism Relat Disord (2008) 1.16
Botanical phenolics and brain health. Neuromolecular Med (2008) 1.11
Characterization of voltage-dependent Ca2+ currents in identified Drosophila motoneurons in situ. J Neurophysiol (2008) 1.09
The epidemiology of Parkinson's disease in an Australian population. Neuroepidemiology (1998) 1.08
Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia. Biol Psychiatry (2008) 1.07
dSir2 mediates the increased spontaneous physical activity in flies on calorie restriction. Aging (Albany NY) (2009) 1.07
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level. Brain Res (1996) 1.06
Neuroendocrine control of a sexually dimorphic behavior by a few neurons of the pars intercerebralis in Drosophila. Proc Natl Acad Sci U S A (2002) 1.06
Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease. Brain Res (2010) 1.05
Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster. J Pharmacol Exp Ther (2002) 1.04
Drosophila models pioneer a new approach to drug discovery for Parkinson's disease. Drug Discov Today (2006) 1.01
Modelling Parkinson's disease in Drosophila. Neuromolecular Med (2009) 1.01
Modulation of insect Ca(v) channels by peptidic spider toxins. Toxicon (2006) 1.01
Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signaling. J Pharmacol Exp Ther (2009) 0.98
Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease. Neuroscience (2010) 0.97
Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice. Neuroreport (1995) 0.95
Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease. J Clin Neurosci (1996) 0.94
Dopamine-dependent neurodegeneration in Drosophila models of familial and sporadic Parkinson's disease. Neurobiol Dis (2010) 0.93
The effects of polyphenols on survival and locomotor activity in Drosophila melanogaster exposed to iron and paraquat. Neurochem Res (2009) 0.91
Quantitative evaluation of motor function before and after engraftment of dopaminergic neurons in a rat model of Parkinson's disease. J Biomed Sci (2010) 0.90
Distinct neural circuits reflect sex, sexual maturity, and reproductive status in response to stress in Drosophila melanogaster. Neuroscience (2008) 0.89
Grape extract protects mitochondria from oxidative damage and improves locomotor dysfunction and extends lifespan in a Drosophila Parkinson's disease model. Rejuvenation Res (2009) 0.89
The cannabinoid CP55,940 prolongs survival and improves locomotor activity in Drosophila melanogaster against paraquat: implications in Parkinson's disease. Neurosci Res (2008) 0.89
Endoplasmic reticulum stress-induced cell death in dopaminergic cells: effect of resveratrol. J Mol Neurosci (2009) 0.87
Can calcium antagonists provide a neuroprotective effect in Parkinson's disease? Drugs (1999) 0.85
Parkinson's disease: return of an old prime suspect. Neuron (2007) 0.83
Evidence for postsynaptic modulation of muscle contraction by a Drosophila neuropeptide. Peptides (2008) 0.81
Calcium antagonists decrease capillary wall damage in aging hypertensive rat brain. Neurobiol Aging (2001) 0.81
Interaction between nicotinic and dopaminergic therapies on cognition in a chronic Parkinson model. Brain Res (2009) 0.80
Selectivity of the protective effects of dihydropyridine calcium channel antagonists against the ethanol withdrawal syndrome. Brain Res (2002) 0.78
Effects of the calcium channel blocker nimodipine on nicotine-induced locomotion in rats. Psychopharmacology (Berl) (1996) 0.75
Enhancement by nifedipine of cholinergic-induced depression of locomotor activity in mice. Funct Neurol (1996) 0.75
Physical exercise increases GFAP expression and induces morphological changes in hippocampal astrocytes. Brain Struct Funct (2013) 1.54
Hemispheric brain injury and behavioral deficits induced by severe neonatal hypoxia-ischemia in rats are not attenuated by intravenous administration of human umbilical cord blood cells. Pediatr Res (2009) 0.96
The influence of the Nd:YAG laser bleaching on physical and mechanical properties of the dental enamel. J Biomed Mater Res B Appl Biomater (2009) 0.94
Modulatory effect of resveratrol on SIRT1, SIRT3, SIRT4, PGC1α and NAMPT gene expression profiles in wild-type adult zebrafish liver. Mol Biol Rep (2011) 0.92
Resveratrol and red wine function as antioxidants in the nervous system without cellular proliferative effects during experimental diabetes. Oxid Med Cell Longev (2010) 0.92
Histological asymmetry of the human recurrent laryngeal nerve. J Voice (2010) 0.88
Effects of physical exercise on spatial memory and astroglial alterations in the hippocampus of diabetic rats. Metab Brain Dis (2011) 0.85
Zebrafish as a model organism to evaluate drugs potentially able to modulate sirtuin expression. Zebrafish (2011) 0.83
A novel preclinical rodent model of collagenase-induced germinal matrix/intraventricular hemorrhage. Brain Res (2010) 0.83
Behavior outcome after ischemic and hemorrhagic stroke, with similar brain damage, in rats. Behav Brain Res (2013) 0.81
Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson's disease. Neurosci Res (2009) 0.80
Plasma cytokines levels in aggressive and chronic periodontitis. Acta Odontol Scand (2012) 0.80
Evaluation of estrogen neuroprotective effect on nigrostriatal dopaminergic neurons following 6-hydroxydopamine injection into the substantia nigra pars compacta or the medial forebrain bundle. Neurochem Res (2008) 0.79
Ethanol and acetaldehyde alter NTPDase and 5'-nucleotidase from zebrafish brain membranes. Neurochem Int (2007) 0.78
Histological organization is similar in human vocal muscle and tongue--a study of muscles and nerves. J Voice (2012) 0.77
Activity of IQG-607, a new orally active compound, in a murine model of Mycobacterium tuberculosis infection. Int J Antimicrob Agents (2012) 0.77
Failure of estrogen to protect the substantia nigra pars compacta of female rats from lesion induced by 6-hydroxydopamine. Brain Res (2003) 0.77
Chronic ethanol treatment alters purine nucleotide hydrolysis and nucleotidase gene expression pattern in zebrafish brain. Neurotoxicology (2011) 0.77
Degree of myelination (g-ratio) of the human recurrent laryngeal nerve. Eur Arch Otorhinolaryngol (2013) 0.77
Pyrimidin-2(1H)-ones based inhibitors of Mycobacterium tuberculosis orotate phosphoribosyltransferase. Eur J Med Chem (2012) 0.76
Degradation of tissue conditioners in complete dentures: an in situ study. Int J Prosthodont (2009) 0.76
Antiepileptic effect of acylpolyaminetoxin JSTX-3 on rat hippocampal CA1 neurons in vitro. Brain Res (2005) 0.76
Physical exercise down-regulated locomotor side effects induced by haloperidol treatment in Wistar rats. Pharmacol Biochem Behav (2013) 0.75
NADPH-diaphorase activity in the nociceptive pathways of land snail Megalobulimus abbreviatus: the involvement of pedal ganglia. Invert Neurosci (2009) 0.75
Sex differences in NADPH-diaphorase activity in the rat posterodorsal medial amygdala. Brain Res (2009) 0.75
Resveratrol prevents akinesia and restores neuronal tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta of diabetic rats. Brain Res (2014) 0.75
Antidepressant Effects of Ketamine Are Not Related to ¹⁸F-FDG Metabolism or Tyrosine Hydroxylase Immunoreactivity in the Ventral Tegmental Area of Wistar Rats. Neurochem Res (2015) 0.75
Sexual dimorphism in the human vocal fold innervation. J Voice (2013) 0.75
Morphology of fetal vocal fold and associated structures. J Voice (2012) 0.75
Morphologic evaluation of the fetal recurrent laryngeal nerve and motor units in the thyroarytenoid muscle. J Voice (2013) 0.75